All Issue

2016 Vol.5, Issue 3 Preview Page
2016. pp. 357~373
Abstract
Sorry, not available.
Click the PDF button.
References
  1. Amin, A., 1999, An institutionalist perspective on regional economic development, International Journal of Urban and Regional Research, 23(2), 365–378.
  2. Amin, A. and Thrift, N., 1994, Globalization, Institutions, and Regional Development in Europe, Oxford: Oxford University Press.
  3. Apple, R.D., 1989, Patenting university research, Isis, 80, 375–94.
  4. Asheim, B., Cooke, P., and Martin, R., 2006, Clusters and Regional Development: Critical Reflections and Explorations, New York: Routledge.
  5. Asheim, B. and Gertler, M., 2005, The geography of innovation: Regional innovation systems, in Fagerberg, J., Mowery, D., and Nelson, R. eds., The Oxford Handbook of Innovation, Oxford: Oxford University Press.
  6. Audretsch, D. and Stephan P., 1999, Knowledge spillovers in biotechnology: Sources and incentives, Journal of Evolutionary Economics, 9, 97–107.
  7. Bagchi-Sen, S., Smith, H., and Hall, L., 2004, The US biotechnology industry: Industry dynamics and policy, Environment and Planning C, 22(2), 199–216.
  8. Baker, L. and Deal, B., 2008, CIRM - Interim Economic Impact Review, San Francisco: Institute for Regenerative Medicine.
  9. Birch, K., 2007, Knowledge, space and biotechnology, Geography Compass, 1(5), 1097–1117.
  10. Bramwell, A. and Wolfe, D.A., 2008, Universities and regional economic development: The entrepreneurial University of Waterloo, Research Policy, 37(8), 1175–1187.
  11. Bristow, G., 2005, Everyone’s a ‘winner’: Problematising the discourse of regional competitiveness, Journal of Economic Geography, 5(3), 285–304.
  12. Coenen, L., Moodysson, J., and Asheim, B., 2004, Nodes, networks and proximities: On the knowledge dynamics of the Medicon Valley biotech cluster, European Planning Studies, 12(7), 1003–1018.
  13. Coenen, L., Moodysson, J., Ryan C., Asheim B., and Phillips, P., 2006, Comparing a pharmaceutical and an agro-food bioregion: On the importance of knowledge bases for socio-spatial patterns of innovation, Industry and Innovation, 13(4), 393–414.
  14. Cooke, P., 2005a., Regionally asymmetric knowledge capabilities and open innovation: Exploring ‘globalisation 2’ – a new model of industry organization, Research Policy, 34(8), 1128–1149.
  15. Cooke, P., 2005b, Rational drug design, the knowledge value chain and bioscience megacentres, Cambridge Journal of Economics, 29(3), 325–341.
  16. Cooke, P., 2006, Global bioregional networks: A new economic geography of bioscientific knowledge, European Planning Studies, 14(9), 1265–1285.
  17. Cooke, P. and Leydesdorff, L., 2006, Regional development in the knowledge-based economy: The construction of advantage, The Journal of Technology Transfer, 31(1), 5–15.
  18. Cooke, P., Heidenreich, M., and Braczyk, H.-J., 2004, Regional Innovation Systems: The Role of Governance in a Globalized World, New York: Routledge.
  19. De la Mothe, J. and Mallory, G., 2004, Local knowledge and the strategy of constructing advantage: The role of community alliances, International Journal of Technology Management, 27(8), 809–820.
  20. DeVol, R.C., Bedroussian, A., Babayan, A., Frye, M., Murphy, D., Philipson, T., Wallace, L., Wong, P., and Yeo, B., 2006, Mind to Market: A Global Analysis of University Biotechnology Transfer and Commercialization. Santa Monica: Milken Institute.
  21. Doyle, J., 2006, Stem cell research holds the promise for tomorrow, Wisconsin Technology Network News, http://wistechnology.com/articles/3236/.
  22. Doyle, J., 2008, Grow Wisconsin, http://www.wisgov.state.wi.us/docview.asp?docid=12933.
  23. Etzkowitz, H., 2002, MIT and the Rise of Entrepreneurial Science, New York: Routledge.
  24. Etzkowitz, H., 2008, The Triple Helix: University-Industry-Government Innovation in Action, New York: Routledge.
  25. Etzkowitz, H. and Leydesdorff, L., 1997, Universities and the Global Knowledge Economy: A Triple Helix of University-Industry-Government Relations, London: Pinter.
  26. Feldman, M., 2000, Where science comes to life: University bioscience, commercial spin-offs, and regional economic development, Journal of Comparative Policy Analysis, 2(3), 345–361.
  27. Feldman, M. and Lendel, I., 2010, Under the lens: The geography of optical science as an emerging industry, Economic Geography, 86(2), 147–171.
  28. Gertler, M. and Vinodrai, T., 2009, Life sciences and regional innovation: One path or many?, European Planning Studies, 17(2), 235–261.
  29. Groves, E., 2004, Governor Doyle outlines Wisconsin's strategy to remain at the forefront of biotechnology, health sciences, and stem cell research, http://www.wisgov.state.wi.us/journal_media_detail.asp?prid=832.
  30. Holden, C., 2007, Prominent researchers join the attack on stem cell patents, Science, 317(5835), 187.
  31. Jain, S. and George, G., 2007, Technology transfer offices as institutional entrepreneurs: The case of Wisconsin Alumni Research Foundation and human embryonic stem cells, Industrial and Corporate Change, 16(4), 535–567.
  32. Kenney, M. and Patton, D., 2005, Entrepreneurial geographies: Support networks in three high-technology industries, Economic Geography, 81(2), 201–228.
  33. Komori, S., 2015, Fujifilm’s Initiatives in Regenerative Medicine, Fujifilm Holdings Corporation.
  34. Roger, L. and Wills, J., 1997, Geographies of Economies, New York: Arnold.
  35. Livingstone, D., 2003, Putting Science in its Place: Geographies of Scientific Knowledge, Chicago: University of Chicago Press.
  36. Martin, R., 2000, Institutional approaches in economic geography, in Sheppard, E. and Barnes, T. eds., A Companion to Economic Geography, Malden: Blackwell.
  37. McCormick, J.B., Owen-Smith, J., and Scott, C., 2009, Distribution of human embryonic stem cell lines: Who, when, and where, Cell Stem Cell, 4(2), 107–110.
  38. Monroe, K., Miller, R., and Tobis, J., 2008, Fundamentals of the Stem Cell Debate: The Scientific, Religious, Ethical, and Political Issues, Berkeley: University of California Press.
  39. Moodysson, J., 2008, Principles and practices of knowledge creation: On the organization of ‘buzz’and ‘pipelines’ in life science communities, Economic Geography, 84(4), 449–469.
  40. Morgridge Institute for Research, 2008, Big bang discovery, Journal of Discovery, 20–25.
  41. Moses III, H., Dorsey, E., Matheson, D., and Their, S., 2005, Financial anatomy of biomedical research, JAMA, 294(11), 1333–1342.
  42. Mowery, D. and Sampat, B., 2005, Universities in national innovation systems, in Fagerberg, D., Mowery, C., and Nelson, R. eds., The Oxford Handbook of Innovation, Oxford: Oxford University Press.
  43. Niosi, J. and Bas, T., 2003, Biotechnology megacentres: Montreal and Toronto regional innovation systems, European Planning Studies, 11(7), 789–804.
  44. Niosi, J. and Bas, T., 2004, Canadian biotechnology policy: Designing incentives for a new technology, Environment and Planning C, 22(2), 233–248.
  45. OECD, 2009, The Bioeconomy to 2030: Designing a Policy Agenda, Paris: OECD Publishing.
  46. Owen-Smith, J. and McCormick, J., 2006, An international gap in human ES cell research, Nature Biotechnology, 24(4), 391–392.
  47. Plomer, A., Taymor, K., and Scott, C., 2008, Challenges to human embryonic stem cell patents, Cell Stem Cell, 2(1), 13–17.
  48. Porter, M., 2008, On Competition, Boston: Harvard Business School.
  49. Prevezer, M., 1997, The dynamics of industrial clustering in biotechnology, Small Business Economics, 9 (3), 255–271.
  50. Rothaermel, F., Agung S., and Jiang, L., 2007, University entrepreneurship: A taxonomy of the literature, Industrial and Corporate Change, 16(4), 691–791.
  51. Sampat, B. and Nelson, R., 2002, The evolution of university patenting and licensing procedures: An empirical study of institutional change, Advances in Strategic Management, 19, 135–166.
  52. Shamblott, M., Axelman, J., Wang, S., Bugg, E., Littlefield, J., Donovan, P., Blumenthal, P., Huggins, G., and Gearhart, J., 1998, Derivation of pluripotent stem cells from cultured human primordial germ cells, Proceedings of the National Academy of Sciences of the United States of America, 95(23), 13726–13731.
  53. Shelley, F., Archer, J., Davidson, F., and Brunn, S., 1996, Political Geography of the United States, New York: Guilford Press.
  54. Stark, J., 1996, The Wisconsin idea: The university's service to the state, http://www.legis.state.wi.us.
  55. Stateline.org., 2008, State of the States, http://www.pewtrusts.org/en/research-and-analysis/reports/2008/01/25/the-state-of-the-states-2008.
  56. Thomson, J., Itskovitz-Eldor, J., Shapiro, S., Waknitz, M., Swiergiel, J., Marshall, V., and Jones, J., 1998, Embryonic stem cell lines derived from human blastocysts, Science, 282(5391), 1145–1147.
  57. Thrift, N. and Olds, K., 1996, Refiguring the economic in economic geography, Progress in Human Geography, 20, 311–337.
  58. Trippl, M. and Tödtling, F., 2007, Developing biotechnology clusters in non-high technology regions: The case of Austria, Industry & Innovation, 14(1), 47–67.
  59. Trounson, A. and McDonald, C., 2015, Stem cell therapies in clinical trials: Progress and challenges, Cell Stem Cell, 17(2), 11-22.
  60. UW-Madison, 2010, Data Digest 2009–2010, http://www.bpa.wisc.edu/datadigest/DataDigest2009-2010.pdf.
  61. UW-Madison Budget Office, http://www.bpa.wisc.edu/datadigest/.
  62. Van Beuzekom, B. and Arundel, A., 2009, OECD Biotechnology Statistics 2009, Paris: OECD.
  63. Vogel, G., 1999, Breakthrough of the year: Capturing the promise of youth, Science, 286 (5448), 2238–2239.
  64. Vogel, G., 2002, In the Mideast, pushing back the stem cell frontier, Science, 295(5561), 1818–1820.
  65. Yu, J., Vodyanik, M., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J., Tian, S., Nie, J., Jonsdottir, G., Ruotti, V., Stewart, R., Slukvin, I., and Thomson, J., 2007, Induced pluripotent stem cell lines derived from human somatic cells, Science, 318(5858), 1917–1920.
  66. Zucker, L., Darby, M., and Brewer, M., 1998, Intellectual human capital and the birth of US biotechnology enterprises, The American Economic Review, 88(1), 290–306.
  67. Milwaukee Journal Sentinel, 1998-11-1, “UW makes transplant breakthrough”.
  68. Milwaukee Journal Sentinel, 2006-4-26, “Doyle signs order to market state as research center”.
  69. PBS, 2005, “The politics of stem cells”, http://www.pbs.org/wgbh/nova/sciencenow/dispatches/050413.html.
  70. The Capital Times, 1998-11-5, “UW reports cell breakthrough”.
  71. Time, 2008-5-12, “Shinya Yamanaka & James Thomson”.
  72. Washington Post, 199811-6, “A crucial human cell is isolated, multiplied: Embryonic building block’s therapeutic potential stirs debate”.
  73. Wisconsin State Journal, 1999-1-28, “Governor spotlights children; Clinton-esque speech focuses on needy kids”.
  74. Wisconsin Technology Network News, 2008-12-19, “Wisconsin stem cell industry has been slow in developing”.
  75. Wisconsin State Journal, 2007-5-17, “UW to open stem-cell center”.
  76. BiotechProfiles, www.biotechprofiles,com
  77. BioPharmGuy, www.biopharmguy.com
  78. National Science Foundation, http://www.nsf.gov/statistics/rdexpenditures
  79. The Wisconsin Idea, http://wisconsinidea.wisc.edu
  80. Wisconsin Alumni Research Foundation, http://www.warf.org
Information
  • Publisher :The Association of Korean Geographers
  • Publisher(Ko) :한국지리학회
  • Journal Title :Journal of the Association of Korean Geographers
  • Journal Title(Ko) :한국지리학회지
  • Volume : 5
  • No :3
  • Pages :357~373